Loading clinical trials...
Loading clinical trials...
The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.
In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study. Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Centre de Recherches Médicales de Lammbaréné
Lambaréné, Moyen-Ogooué Province, Gabon
Centre de Recherches Médicales de Lambréné
Lambaréne, Gabon
Start Date
August 1, 2020
Primary Completion Date
December 31, 2021
Completion Date
March 1, 2022
Last Updated
July 19, 2022
574
ACTUAL participants
Lead Sponsor
Centre de Recherche Médicale de Lambaréné
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04510025